The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Eye drops are saline-containing drops used as an ocular route to administer.
The global Eye Drops market was valued at US$ 9038.4 million in 2023 and is anticipated to reach US$ 9956.2 million by 2030, witnessing a CAGR of 1.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Eye Drops, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Drops.
Report Scope
The Eye Drops market size, estimations, and forecasts are provided in terms of sales volume (K Boxes) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eye Drops market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eye Drops manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alcon
Bausch and Lomb
Mentholatum
Lion
ZSM
Johnson & Johnson Services
Shapuaisi Pharmaceutical
Renhe
Santen
Abbott Laboratories
Rohto Pharmaceutical
Sigma Pharmaceuticals
Novartis AG
Allergan
Meda Pharmaceuticals
Cigna
Similasan Corporation
TianMuShan Pharmaceutical
Segment by Type
Over-the-Counter Eye Drops
Prescription Eye Drops
Segment by Application
Drug Store
Hospital Pharmacies
Online
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eye Drops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eye Drops in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Eye drops are saline-containing drops used as an ocular route to administer.
The global Eye Drops market was valued at US$ 9038.4 million in 2023 and is anticipated to reach US$ 9956.2 million by 2030, witnessing a CAGR of 1.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Eye Drops, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Drops.
Report Scope
The Eye Drops market size, estimations, and forecasts are provided in terms of sales volume (K Boxes) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eye Drops market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eye Drops manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alcon
Bausch and Lomb
Mentholatum
Lion
ZSM
Johnson & Johnson Services
Shapuaisi Pharmaceutical
Renhe
Santen
Abbott Laboratories
Rohto Pharmaceutical
Sigma Pharmaceuticals
Novartis AG
Allergan
Meda Pharmaceuticals
Cigna
Similasan Corporation
TianMuShan Pharmaceutical
Segment by Type
Over-the-Counter Eye Drops
Prescription Eye Drops
Segment by Application
Drug Store
Hospital Pharmacies
Online
Consumption by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eye Drops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eye Drops in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Eye Drops Market Overview
1.1 Product Overview and Scope of Eye Drops
1.2 Eye Drops Segment by Type
1.2.1 Global Eye Drops Market Value Comparison by Type (2024-2030)
1.2.2 Over-the-Counter Eye Drops
1.2.3 Prescription Eye Drops
1.3 Eye Drops Segment by Application
1.3.1 Global Eye Drops Market Value by Application: (2024-2030)
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Global Eye Drops Market Size Estimates and Forecasts
1.4.1 Global Eye Drops Revenue 2019-2030
1.4.2 Global Eye Drops Sales 2019-2030
1.4.3 Global Eye Drops Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Eye Drops Market Competition by Manufacturers
2.1 Global Eye Drops Sales Market Share by Manufacturers (2019-2024)
2.2 Global Eye Drops Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Eye Drops Average Price by Manufacturers (2019-2024)
2.4 Global Eye Drops Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eye Drops, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eye Drops, Product Type & Application
2.7 Eye Drops Market Competitive Situation and Trends
2.7.1 Eye Drops Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Eye Drops Players Market Share by Revenue
2.7.3 Global Eye Drops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Eye Drops Retrospective Market Scenario by Region
3.1 Global Eye Drops Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Eye Drops Global Eye Drops Sales by Region: 2019-2030
3.2.1 Global Eye Drops Sales by Region: 2019-2024
3.2.2 Global Eye Drops Sales by Region: 2025-2030
3.3 Global Eye Drops Global Eye Drops Revenue by Region: 2019-2030
3.3.1 Global Eye Drops Revenue by Region: 2019-2024
3.3.2 Global Eye Drops Revenue by Region: 2025-2030
3.4 North America Eye Drops Market Facts & Figures by Country
3.4.1 North America Eye Drops Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Eye Drops Sales by Country (2019-2030)
3.4.3 North America Eye Drops Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Eye Drops Market Facts & Figures by Country
3.5.1 Europe Eye Drops Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Eye Drops Sales by Country (2019-2030)
3.5.3 Europe Eye Drops Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eye Drops Market Facts & Figures by Country
3.6.1 Asia Pacific Eye Drops Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Eye Drops Sales by Country (2019-2030)
3.6.3 Asia Pacific Eye Drops Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Eye Drops Market Facts & Figures by Country
3.7.1 Latin America Eye Drops Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Eye Drops Sales by Country (2019-2030)
3.7.3 Latin America Eye Drops Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eye Drops Market Facts & Figures by Country
3.8.1 Middle East and Africa Eye Drops Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Eye Drops Sales by Country (2019-2030)
3.8.3 Middle East and Africa Eye Drops Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eye Drops Sales by Type (2019-2030)
4.1.1 Global Eye Drops Sales by Type (2019-2024)
4.1.2 Global Eye Drops Sales by Type (2025-2030)
4.1.3 Global Eye Drops Sales Market Share by Type (2019-2030)
4.2 Global Eye Drops Revenue by Type (2019-2030)
4.2.1 Global Eye Drops Revenue by Type (2019-2024)
4.2.2 Global Eye Drops Revenue by Type (2025-2030)
4.2.3 Global Eye Drops Revenue Market Share by Type (2019-2030)
4.3 Global Eye Drops Price by Type (2019-2030)
5 Segment by Application
5.1 Global Eye Drops Sales by Application (2019-2030)
5.1.1 Global Eye Drops Sales by Application (2019-2024)
5.1.2 Global Eye Drops Sales by Application (2025-2030)
5.1.3 Global Eye Drops Sales Market Share by Application (2019-2030)
5.2 Global Eye Drops Revenue by Application (2019-2030)
5.2.1 Global Eye Drops Revenue by Application (2019-2024)
5.2.2 Global Eye Drops Revenue by Application (2025-2030)
5.2.3 Global Eye Drops Revenue Market Share by Application (2019-2030)
5.3 Global Eye Drops Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Alcon
6.1.1 Alcon Corporation Information
6.1.2 Alcon Description and Business Overview
6.1.3 Alcon Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Alcon Eye Drops Product Portfolio
6.1.5 Alcon Recent Developments/Updates
6.2 Bausch and Lomb
6.2.1 Bausch and Lomb Corporation Information
6.2.2 Bausch and Lomb Description and Business Overview
6.2.3 Bausch and Lomb Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bausch and Lomb Eye Drops Product Portfolio
6.2.5 Bausch and Lomb Recent Developments/Updates
6.3 Mentholatum
6.3.1 Mentholatum Corporation Information
6.3.2 Mentholatum Description and Business Overview
6.3.3 Mentholatum Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mentholatum Eye Drops Product Portfolio
6.3.5 Mentholatum Recent Developments/Updates
6.4 Lion
6.4.1 Lion Corporation Information
6.4.2 Lion Description and Business Overview
6.4.3 Lion Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lion Eye Drops Product Portfolio
6.4.5 Lion Recent Developments/Updates
6.5 ZSM
6.5.1 ZSM Corporation Information
6.5.2 ZSM Description and Business Overview
6.5.3 ZSM Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ZSM Eye Drops Product Portfolio
6.5.5 ZSM Recent Developments/Updates
6.6 Johnson & Johnson Services
6.6.1 Johnson & Johnson Services Corporation Information
6.6.2 Johnson & Johnson Services Description and Business Overview
6.6.3 Johnson & Johnson Services Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Services Eye Drops Product Portfolio
6.6.5 Johnson & Johnson Services Recent Developments/Updates
6.7 Shapuaisi Pharmaceutical
6.6.1 Shapuaisi Pharmaceutical Corporation Information
6.6.2 Shapuaisi Pharmaceutical Description and Business Overview
6.6.3 Shapuaisi Pharmaceutical Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shapuaisi Pharmaceutical Eye Drops Product Portfolio
6.7.5 Shapuaisi Pharmaceutical Recent Developments/Updates
6.8 Renhe
6.8.1 Renhe Corporation Information
6.8.2 Renhe Description and Business Overview
6.8.3 Renhe Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Renhe Eye Drops Product Portfolio
6.8.5 Renhe Recent Developments/Updates
6.9 Santen
6.9.1 Santen Corporation Information
6.9.2 Santen Description and Business Overview
6.9.3 Santen Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Santen Eye Drops Product Portfolio
6.9.5 Santen Recent Developments/Updates
6.10 Abbott Laboratories
6.10.1 Abbott Laboratories Corporation Information
6.10.2 Abbott Laboratories Description and Business Overview
6.10.3 Abbott Laboratories Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Abbott Laboratories Eye Drops Product Portfolio
6.10.5 Abbott Laboratories Recent Developments/Updates
6.11 Rohto Pharmaceutical
6.11.1 Rohto Pharmaceutical Corporation Information
6.11.2 Rohto Pharmaceutical Eye Drops Description and Business Overview
6.11.3 Rohto Pharmaceutical Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Rohto Pharmaceutical Eye Drops Product Portfolio
6.11.5 Rohto Pharmaceutical Recent Developments/Updates
6.12 Sigma Pharmaceuticals
6.12.1 Sigma Pharmaceuticals Corporation Information
6.12.2 Sigma Pharmaceuticals Eye Drops Description and Business Overview
6.12.3 Sigma Pharmaceuticals Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sigma Pharmaceuticals Eye Drops Product Portfolio
6.12.5 Sigma Pharmaceuticals Recent Developments/Updates
6.13 Novartis AG
6.13.1 Novartis AG Corporation Information
6.13.2 Novartis AG Eye Drops Description and Business Overview
6.13.3 Novartis AG Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Novartis AG Eye Drops Product Portfolio
6.13.5 Novartis AG Recent Developments/Updates
6.14 Allergan
6.14.1 Allergan Corporation Information
6.14.2 Allergan Eye Drops Description and Business Overview
6.14.3 Allergan Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Allergan Eye Drops Product Portfolio
6.14.5 Allergan Recent Developments/Updates
6.15 Meda Pharmaceuticals
6.15.1 Meda Pharmaceuticals Corporation Information
6.15.2 Meda Pharmaceuticals Eye Drops Description and Business Overview
6.15.3 Meda Pharmaceuticals Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Meda Pharmaceuticals Eye Drops Product Portfolio
6.15.5 Meda Pharmaceuticals Recent Developments/Updates
6.16 Cigna
6.16.1 Cigna Corporation Information
6.16.2 Cigna Eye Drops Description and Business Overview
6.16.3 Cigna Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Cigna Eye Drops Product Portfolio
6.16.5 Cigna Recent Developments/Updates
6.17 Similasan Corporation
6.17.1 Similasan Corporation Corporation Information
6.17.2 Similasan Corporation Eye Drops Description and Business Overview
6.17.3 Similasan Corporation Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Similasan Corporation Eye Drops Product Portfolio
6.17.5 Similasan Corporation Recent Developments/Updates
6.18 TianMuShan Pharmaceutical
6.18.1 TianMuShan Pharmaceutical Corporation Information
6.18.2 TianMuShan Pharmaceutical Eye Drops Description and Business Overview
6.18.3 TianMuShan Pharmaceutical Eye Drops Sales, Revenue and Gross Margin (2019-2024)
6.18.4 TianMuShan Pharmaceutical Eye Drops Product Portfolio
6.18.5 TianMuShan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eye Drops Industry Chain Analysis
7.2 Eye Drops Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eye Drops Production Mode & Process
7.4 Eye Drops Sales and Marketing
7.4.1 Eye Drops Sales Channels
7.4.2 Eye Drops Distributors
7.5 Eye Drops Customers
8 Eye Drops Market Dynamics
8.1 Eye Drops Industry Trends
8.2 Eye Drops Market Drivers
8.3 Eye Drops Market Challenges
8.4 Eye Drops Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
